Evaluating the Safety and Efficacy of SGLT-2 Inhibitors on Reducing Cardiovascular and Renal Mortality, Morbidity and Inflammatory Outcomes in Various Patient Populations: A Systematic Review and Meta-Analysis of 92 920 Patients.

Clin Med Insights Cardiol · 2025 · PMC12214313 · PMID 40607064

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Validating the findings of Katakami et al 35 that found systolic BP to decrease by 5.6 mmHg from the start to the end of the treatment, our analysis also revealed a highly significant trend when it came to lowering hypertension with this drug.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.